4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-22-000004
Director acquired 1,150 shares (grant or award)
- Director acquired 712 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anderson Kenneth Carl Director | 2022-10-03 | Option exercise | +267 | $2.11 | $563 | 91,253 | D |
| Anderson Kenneth Carl Director | 2022-10-03 | Option exercise | +445 | $4.98 | $2,216 | 91,698 | D |
| Anderson Kenneth Carl Director | 2022-10-03 | Grant or award | +1,150 | $8.69 | $9,994 | 92,848 | D |
| Derivatives | |||||||
| Anderson Kenneth Carl Director | 2022-10-03 | Option exercise · Stock Option (Right to Buy) | −267 | 1,335 | D | ||
| Anderson Kenneth Carl Director | 2022-10-03 | Option exercise · Stock Option (Right to Buy) | −445 | 1,334 | D | ||
Loading xslF345X03/wf-form4_166492110095346.xml…